Deubiquitinating c-Myc: USP36 steps up in the nucleolus

References

• Lin CY, Loven J, Rahl PB, Paranal RM, Burge CB, Bradner JE, Lee TI, Young RA. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012; 151:56-67; PMID:23021215; http://dx.doi.org/10.1016/j.cell.2012.08.026
   PubMed Web of Science ®Google Scholar
• Nie Z, Hu G, Wei G, Cui K, Yamane A, Resch W, Wang R, Green DR, Tessarollo L, Casellas R, et al. c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 2012; 151:68-79; PMID:23021216; http://dx.doi.org/10.1016/j.cell.2012.08.033
   PubMed Web of Science ®Google Scholar
• Sabo A, Kress TR, Pelizzola M, de Pretis S, Gorski MM, Tesi A, Morelli MJ, Bora P, Doni M, Verrecchia A, et al. Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis. Nature 2014; 511: 488-92; PMID:25043028; http://dx.doi.org/10.1038/nature13537
   PubMed Web of Science ®Google Scholar
• Walz S, Lorenzin F, Morton J, Wiese KE, von Eyss B, Herold S, Rycak L, Dumay-Odelot H, Karim S, Bartkuhn M, et al. Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles. Nature 2014; 511:483-7; PMID:25043018; http://dx.doi.org/10.1038/nature13473
   PubMed Web of Science ®Google Scholar
• Adhikary S, Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat Rev Mol Cell Biol 2005; 6:635-45; PMID:16064138; http://dx.doi.org/doi:10.1038/nrm1703
   PubMed Web of Science ®Google Scholar
• Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008; 8:976-90; PMID:19029958; http://dx.doi.org/10.1038/nrc2231
   PubMed Web of Science ®Google Scholar
• van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 2010; 10: 301-9; PMID:19029958; http://dx.doi.org/10.1038/nrc2231
   PubMed Web of Science ®Google Scholar
• Nesbit CE, Tersak JM, aProchownik EV. MYC oncogenes and human neoplastic disease. Oncogene 1999; 18:3004-16; PMID:20332779; http://dx.doi.org/10.1038/nrc2819
   PubMed Web of Science ®Google Scholar
• Farrell AS, Sears RC. MYC degradation. Cold Spring Harb Perspect Med 2014; 4: pii: a014365; PMID:24591536; http://dx.doi.org/10.1101/cshperspect.a014365
   PubMed Web of Science ®Google Scholar
• Hann SR. Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function. Semin Cancer Biol 2006; 16:288-302; PMID:16938463; http://dx.doi.org/10.1016/j.semcancer.2006.08.004; PMID:16938463
   PubMed Web of Science ®Google Scholar
• Sears R, Leone G, DeGregori J, Nevins JR. Ras enhances Myc protein stability. Mol Cell 1999; 3:169-79; PMID:10078200; http://dx.doi.org/10.1016/S1097-2765(00)80308-1
   PubMed Web of Science ®Google Scholar
• Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev 2000;14:2501-14; PMID:11018017; http://dx.doi.org/10.1101/gad.836800
   PubMed Web of Science ®Google Scholar
• Sears RC. The life cycle of C-myc: from synthesis to degradation. Cell cycle 2004; 3:1133-7; PMID:15467447; http://dx.doi.org/10.4161/cc.3.9.1145
   PubMed Web of Science ®Google Scholar
• Conacci-Sorrell M, McFerrin L, Eisenman, RN. An overview of MYC and its interactome. Cold Spring Harb Perspect Med 2014; 4, a014357; PMID:24384812; http://dx.doi.org/10.1101/cshperspect.a014357
   PubMed Web of Science ®Google Scholar
• Tu WB, Helander S, Pilstal R, Hickman KA, Lourenco C, Jurisica I, Raught B, Wallner B, Sunnerhagen M, Penn LZ. Myc and its interactors take shape. Biochim Biophys Acta 2015; 1849:469-83; PMID:24933113; http://dx.doi.org/10.1016/j.bbagrm.2014.06.002
   PubMed Web of Science ®Google Scholar
• Ciechanover A, DiGiuseppe JA, Bercovich B, Orian A, Richter JD, Schwartz AL, Brodeur GM. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc Natl Acad Sci U S A 1991; 88:139-43; PMID:1846034
   PubMed Web of Science ®Google Scholar
• Flinn EM, Busch CM, Wright AP. myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol Cell Biol 1998; 18:5961-69; PMID:9742113
   PubMed Web of Science ®Google Scholar
• Lutterbach B, Hann SR. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol 1994; 14:5510-22; PMID:8035827; http://dx.doi.org/10.1128/MCB.14.8.5510
   PubMed Web of Science ®Google Scholar
• Gregory MA, Qi Y, Hann SR. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem 2003; 278:51606-12; PMID:14563837; http://dx.doi.org/10.1074/jbc.M310722200
   PubMed Web of Science ®Google Scholar
• Chang DW, Claassen GF, Hann SR, Cole MD. The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals. Mol Cell Biol 2000; 20:4309-19; PMID:10825194; http://dx.doi.org/10.1128/MCB.20.12.4309-4319.2000
   PubMed Web of Science ®Google Scholar
• Lutterbach B, aHann SR. Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens and in mitosis. Mol Cell Biol 1994; 14:5510-22; PMID:8035827; http://dx.doi.org/10.1128/MCB.14.8.5510
   PubMed Web of Science ®Google Scholar
• Oster SK, Ho CS, Soucie EL, Penn LZ. The myc oncogene: MarvelouslY Complex. Adv Cancer Res 2002; 84:81-154; PMID:11885563; http://dx.doi.org/10.1016/S0065-230X(02)84004-0
   PubMed Web of Science ®Google Scholar
• Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 2004; 6:308-18; PMID:15048125; http://dx.doi.org/10.1038/ncb1110
   PubMed Web of Science ®Google Scholar
• Moberg KH, Mukherjee A, Veraksa A, Artavanis-Tsakonas S, Hariharan IK. The Drosophila F box protein archipelago regulates dMyc protein levels in vivo. Curr Biol 2004; 14:965-74; PMID:15182669; http://dx.doi.org/10.1016/j.cub.2004.04.040
   PubMed Web of Science ®Google Scholar
• Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23:2116-25; PMID:15103331; http://dx.doi.org/10.1038/sj.emboj.7600217
   PubMed Web of Science ®Google Scholar
• Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, Clurman B E. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci U S A 2004; 101:9085-90; PMID:15150404; http://dx.doi.org/10.1073/pnas.0402770101
   PubMed Web of Science ®Google Scholar
• Welcker M, Orian A, Grim JE, Eisenman RN, Clurman BE. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr Biol 2004; 14:965-74; PMID:15498494; http://dx.doi.org/10.1016/j.cub.2004.09.083
   PubMed Web of Science ®Google Scholar
• Bahram F, von der Lehr N, Cetinkaya C, Larsson LG. c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood 2000; 95:2104-10; PMID:10706881
   PubMed Web of Science ®Google Scholar
• Gregory MA, Hann SR. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol. 2000; 20:2423-35; PMID:10713166; http://dx.doi.org/10.1128/MCB.20.7.2423-2435.2000
   PubMed Web of Science ®Google Scholar
• Salghetti SE, Kim SY, Tansey WP. Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 1999; 18, 717-26; PMID:9927431
   PubMed Web of Science ®Google Scholar
• Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, Cleveland JL, Tansey WP, Lowe SW. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants. Nature 2005; 436:807-11; PMID:16094360; http://dx.doi.org/10.1038/nature03845
   PubMed Web of Science ®Google Scholar
• Wang X, Cunningham M, Zhang X, Tokarz S, Laraway B, Troxell M, Sears RC. Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland. Cancer Res 2011; 71:925-36; PMID:21266350; http://dx.doi.org/10.1158/0008-5472.CAN-10-1032
   PubMed Web of Science ®Google Scholar
• Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008; 8:83-93; PMID:18094723; http://dx.doi.org/10.1038/nrc2290
   PubMed Web of Science ®Google Scholar
• von der Lehr N, Johansson S, Wu S, Bahram F, Castell A, Cetinkaya C, Hydbring P, Weidung I, Nakayama K, Nakayama KI, et al. The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell 2003; 11:1189-200; PMID:12769844; http://dx.doi.org/10.1016/S1097-2765(03)00193-X
   PubMed Web of Science ®Google Scholar
• von der Lehr N, Johansson S, Larsson LG. Implication of the ubiquitin/proteasome system in Myc-regulated transcription. Cell Cycle 2003; 2:403-7; PMID:12963825; http://dx.doi.org/10.4161/cc.2.5.484
   PubMed Web of Science ®Google Scholar
• Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tansey WP. Skp2 regulates Myc protein stability and activity. Mol Cell 2003; 11:1177-88; PMID:12769843; http://dx.doi.org/10.1016/S1097-2765(03)00173-4
   PubMed Web of Science ®Google Scholar
• Zhang Q, Spears E, Boone DN, Li Z, Gregory MA, Hann SR. Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity. Proc Natl Acad Sci U S A 2013; 110:978-83; PMID:23277542; http://dx.doi.org/10.1073/pnas.1208334110
   PubMed Web of Science ®Google Scholar
• Farrell AS, Pelz C, Wang X, Daniel CJ, Wang Z, Su Y, Janghorban M, Zhang X, Morgan C, Impey S, et al. Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis. Mol Cell Biol 2013; 33:2930-49; PMID:23716601; http://dx.doi.org/10.1128/MCB.01455-12
   PubMed Web of Science ®Google Scholar
• Chan CH, Lee SW, Li CF, Wang J, Yang WL, Wu CY, Wu J, Nakayama KI, Kang HY, Huang HY, et al. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat Cell Biol 2010;12:457-67; PMID:20383141; http://dx.doi.org/10.1038/ncb2047
   PubMed Web of Science ®Google Scholar
• Li X, Bian Y, Takizawa Y, Hashimoto T, Ikoma T, Tanaka J, Kitamura N, Inagaki Y, Komada M, Tanaka T. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression. Mol Cancer Res 2013; 11:1437-47; PMID:24177224; http://dx.doi.org/10.1158/1541-7786.MCR-12-0718
   PubMed Web of Science ®Google Scholar
• Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R, Bernard S, Quarto M, Capra M, Goettig S, et al. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 2005; 123:409-21; PMID:16269333; http://dx.doi.org/10.1016/j.cell.2005.08.016
   PubMed Web of Science ®Google Scholar
• Peter S, Bultinck J, Myant K, Jaenicke LA, Walz S, Muller J, Gmachl M, Treu M, Boehmelt G, Ade CP, et al. Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase. EMBO Mol Med 2014; 6:1525-41; PMID:25253726; http://dx.doi.org/10.15252/emmm.201403927
   PubMed Web of Science ®Google Scholar
• Cepeda D, Ng HF, Sharifi HR, Mahmoudi S, Cerrato VS, Fredlund E, Magnusson K, Nilsson H, Malyukova A, Rantala J, et al. CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer. EMBO Mol Med 2013; 5:999-1018; PMID:23776131; http://dx.doi.org/10.1002/emmm.201202341
   PubMed Web of Science ®Google Scholar
• Popov N, Schulein C, Jaenicke LA, Eilers M. Ubiquitylation of the amino terminus of Myc by SCF(β-TrCP) antagonizes SCF(Fbw7)-mediated turnover. Nat Cell Biol 2010; 12:973-81; PMID:20852628; http://dx.doi.org/10.1038/ncb2104
   PubMed Web of Science ®Google Scholar
• Yi YW, Kang HJ, Bae EJ, Oh S, Seong YS, Bae I. β-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells. Exp Mol Med 2015; 47, e143; PMID:25721419; http://dx.doi.org/10.1038/emm.2014.127
   PubMed Web of Science ®Google Scholar
• Choi SH, Wright JB, Gerber SA, Cole MD. Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells. Genes Dev 2010; 24:1236-41; PMID:20551172; http://dx.doi.org/10.1101/gad.1920310
   PubMed Web of Science ®Google Scholar
• Jamal A, Swarnalatha M, Sultana S, Joshi P, Panda SK, Kumar V. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2. Cell Cycle, 2015; 14:2688-700; PMID:26038816; http://dx.doi.org/10.1080/15384101.2015.1056946
   PubMed Web of Science ®Google Scholar
• Schwamborn JC, Berezikov E, Knoblich JA. The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. Cell 2009; 136:913-25; PMID:19269368; http://dx.doi.org/10.1016/j.cell.2008.12.024
   PubMed Web of Science ®Google Scholar
• Hakem A, Bohgaki M, Lemmers B, Tai E, Salmena L, Matysiak-Zablocki E, Jung YS, Karaskova J, Kaustov L, Duan S, et al. Role of Pirh2 in mediating the regulation of p53 and c-Myc. PLoS genetics 2011; 7:e1002360; PMID:22125490; http://dx.doi.org/10.1371/journal.pgen.1002360
   PubMed Web of Science ®Google Scholar
• Ballinger CA, Connell P, Wu Y, Hu Z, Thompson LJ, Yin LY, Patterson C. Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions. Mol Cell Biol 1999; 19:4535-45; PMID:10330192
   PubMed Web of Science ®Google Scholar
• Paul I, Ahmed SF, Bhowmik A, Deb S, Ghosh MK. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity. Oncogene 2013; 32:1284-95; PMID:22543587; http://dx.doi.org/10.1038/onc.2012.144
   PubMed Web of Science ®Google Scholar
• Mei Z, Zhang D, Hu B, Wang J, Shen X, a Xiao W. FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity. J Biol Chem 2015; 290:16202-14; PMID:25944903; http://dx.doi.org/10.1074/jbc.M115.645978
   PubMed Web of Science ®Google Scholar
• Komander D, Clague MJ, Urbe S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 2009; 10:550-63; PMID:19626045; http://dx.doi.org/10.1038/nrm2731
   PubMed Web of Science ®Google Scholar
• Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, Bernards R. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005; 123:773-86; PMID:16325574; http://dx.doi.org/10.1016/j.cell.2005.11.007
   PubMed Web of Science ®Google Scholar
• Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R, Moll R, Elledge SJ, Eilers M. The ubiquitin-specific protease USP28 is required for MYC stability. Nat Cell Biol 2007; 9:765-74; PMID:17558397; http://dx.doi.org/10.1038/ncb1601
   PubMed Web of Science ®Google Scholar
• Popov N, Herold S, Llamazares M, Schulein C, Eilers M. Fbw7 and Usp28 regulate myc protein stability in response to DNA damage. Cell cycle 2007; 6:2327-31; PMID:17873522; http://dx.doi.org/10.1016/j.celrep.2014.09.057
   PubMed Web of Science ®Google Scholar
• Schulein-Volk C, Wolf E, Zhu J, Xu W, Taranets L, Hellmann A, Janicke LA, Diefenbacher ME, Behrens A, Eilers M, et al. Dual regulation of Fbw7 function and oncogenic transformation by Usp28. Cell Rep 2014; 9:1099-109; PMID:25437563; http://dx.doi.org/10.1016/j.celrep.2014.09.057
   PubMed Web of Science ®Google Scholar
• Diefenbacher ME, Chakraborty A, Blake SM, Mitter R, Popov N, Eilers M, Behrens A. Usp28 counteracts Fbw7 in intestinal homeostasis and cancer. Cancer Res 2015; 75:1181-6; PMID:25716680; http://dx.doi.org/10.1158/0008-5472.CAN-14-1726
   PubMed Web of Science ®Google Scholar
• Pan J, Deng Q, Jiang C, Wang X, Niu T, Li H, Chen T, Jin J, Pan W, Cai X, et al. USP37 directly deubiquitinates and stabilizes c-Myc in lung cancer. Oncogene 2015; 34:3957-67; PMID:25284584; http://dx.doi.org/10.1038/onc.2014.327
   PubMed Web of Science ®Google Scholar
• Arabi A, Wu S, Ridderstrale K, Bierhoff H, Shiue C, Fatyol K, Fahlen S, Hydbring P, Soderberg O, Grummt I, et al. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol 2005; 7:303-10; PMID:15723053; http://dx.doi.org/10.1038/ncb1225
   PubMed Web of Science ®Google Scholar
• Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman RN, White RJ. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nat Cell Biol 2005; 7:311-8; PMID:15723054; http://dx.doi.org/10.1038/ncb1224
   PubMed Web of Science ®Google Scholar
• Dai MS, Lu H. Crosstalk between c-Myc and ribosome in ribosomal biogenesis and cancer. J Cell Biochem 2008; 105:670-7; PMID:18773413; http://dx.doi.org/10.1002/jcb.21895
   PubMed Web of Science ®Google Scholar
• van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 2010; 10:301-9; PMID:20332779; http://dx.doi.org/10.1038/nrc2819
   PubMed Web of Science ®Google Scholar
• Sun XX, He X, Yin L, Komada M, Sears RC, Dai MS. The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc. Proc Natl Acad Sci U S A 2015; 112:3734-9; PMID:25775507; http://dx.doi.org/10.1073/pnas.1411713112
   PubMed Web of Science ®Google Scholar
• Li J, Olson LM, Zhang Z, Li L, Bidder M, Nguyen L, Pfeifer J, Rader JS. Differential display identifies overexpression of the USP36 gene, encoding a deubiquitinating enzyme, in ovarian cancer. Int J Med Sci 2008; 5:133-42; PMID:18566677; http://dx.doi.org/10.7150/ijms.5.133
   PubMedGoogle Scholar
• Endo A, Kitamura N, Komada M. Nucleophosmin/B23 regulates ubiquitin dynamics in nucleoli by recruiting deubiquitylating enzyme USP36. J Biol Chem 2009; 284:27918-23; PMID:19679658; http://dx.doi.org/10.1074/jbc.M109.037218
   PubMed Web of Science ®Google Scholar
• Endo A, Matsumoto M, Inada T, Yamamoto A, Nakayama KI, Kitamura N, Komada M. Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36. J Cell Sci 2009; 122:678-86; PMID:19208757; http://dx.doi.org/10.1242/jcs.044461
   PubMed Web of Science ®Google Scholar
• Richardson LA, Reed BJ, Charette JM, Freed EF, Fredrickson EK, Locke MN, Baserga SJ, Gardner RG. A conserved deubiquitinating enzyme controls cell growth by regulating RNA polymerase I stability. Cell Rep 2012; 2:372-85; PMID:22902402; http://dx.doi.org/10.1016/j.celrep.2012.07.009
   PubMed Web of Science ®Google Scholar
• Taillebourg E, Gregoire I, Viargues P, Jacomin AC, Thevenon D, Faure M, Fauvarque MO. The deubiquitinating enzyme USP36 controls selective autophagy activation by ubiquitinated proteins. Autophagy 2012; 8:767-79; PMID:22622177; http://dx.doi.org/10.4161/auto.19381
   PubMed Web of Science ®Google Scholar
• Thevenon D, Engel E, Avet-Rochex A, Gottar M, Bergeret E, Tricoire H, Benaud C, Baudier J, Taillebourg E, Fauvarque MO. The Drosophila ubiquitin-specific protease dUSP36/Scny targets IMD to prevent constitutive immune signaling. Cell Host Microbe 2009; 6:309-20; PMID:19837371; http://dx.doi.org/10.1016/j.chom.2009.09.007
   PubMed Web of Science ®Google Scholar
• Amati B, Sanchez-Arevalo Lobo VJ. MYC degradation: deubiquitinating enzymes enter the dance. Nat Cell Biol 2007; 9:729-31; PMID:17603505; http://dx.doi.org/10.1038/ncb0707-729
   PubMed Web of Science ®Google Scholar